Dexcom (DXCM) Receivables - Other (2018 - 2026)

Dexcom (DXCM) has 9 years of Receivables - Other data on file, last reported at $16.9 million in Q1 2026.

• Receivables - Other for Q1 2026 came in at $16.9 million, up 14.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.9 million (up 14.97% YoY), and the FY2025 annual result was $16.9 million, up 11.18% from the prior year.
• Receivables - Other was little changed at $16.9 million in Q1 2026 per DXCM's latest filing, from $16.9 million in the prior quarter.
• Over five years, Receivables - Other peaked at $17.0 million in Q2 2025 and troughed at $8.0 million in Q4 2023.
• A 5-year average of $12.3 million and a median of $10.3 million in 2022 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other retreated 16.22% in 2022, then soared 90.0% in 2024.
• A 5-year view of Receivables - Other shows it stood at $9.0 million in 2022, then fell by 11.11% to $8.0 million in 2023, then soared by 90.0% to $15.2 million in 2024, then grew by 11.18% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
• Business Quant data shows DXCM's Receivables - Other at $16.9 million in Q1 2026, $16.9 million in Q4 2025, and $16.6 million in Q3 2025.